Instil Bio Inc (TIL)
65.62
-2.74
(-4.01%)
USD |
NASDAQ |
Sep 27, 16:00
65.80
+0.18
(+0.27%)
After-Hours: 20:00
Instil Bio Cash from Operations (Quarterly): -10.61M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -10.61M |
| March 31, 2024 | -14.39M |
| December 31, 2023 | -13.38M |
| September 30, 2023 | -14.43M |
| June 30, 2023 | -19.56M |
| March 31, 2023 | -34.66M |
| December 31, 2022 | -36.98M |
| September 30, 2022 | -40.88M |
| June 30, 2022 | -47.26M |
| Date | Value |
|---|---|
| March 31, 2022 | -55.05M |
| December 31, 2021 | -42.79M |
| September 30, 2021 | -29.40M |
| June 30, 2021 | -32.22M |
| March 31, 2021 | -17.73M |
| December 31, 2020 | -16.82M |
| September 30, 2020 | -7.235M |
| June 30, 2020 | -3.276M |
| March 31, 2020 | -2.282M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-55.05M
Minimum
Mar 2022
-2.282M
Maximum
Mar 2020
-24.39M
Average
-18.64M
Median
Cash from Operations (Quarterly) Benchmarks
| Merck & Co Inc | 5.637B |
| BioCardia Inc | -1.312M |
| Zevra Therapeutics Inc | -19.11M |
| PetIQ Inc | 57.88M |
| SeaStar Medical Holding Corp | -2.824M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 11.92M |
| Free Cash Flow | -52.81M |
| Free Cash Flow Per Share (Quarterly) | -1.632 |
| Free Cash Flow Yield | -12.37% |